New Transdermal Curcumin Gel Shows Promise for Acute Pain Relief in Sickle Cell Disease Vascarta Inc. has unveiled a groundbreaking transdermal curcumin gel that alleviates acute pain in sickle cell disease, paving the way for innovative treatments.

New Transdermal Curcumin Gel Shows Promise for Acute Pain Relief in Sickle Cell Disease #USA #sickle_cell_disease #Vascarta #Summit #Curcumin_Gel